MiMedx Group (MDXG) Stock Chart & Stock Price History → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free MDXG Stock Alerts $7.37 -0.13 (-1.73%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MiMedx Group Stock Price Performance5 Day Performance+17.73%1 Month Performance+4.99%3 Month Performance-5.15%6 Month Performance+8.06%Year-To-Date Performance-15.96%1 Year Performance+33.27% Receive MDXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. MDXG Stock Chart for Saturday, May, 4, 2024 MDXG Chart by TradingView MiMedx Group Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$7.50$7.37-1.73%$7.75$7.36832,074 shs$1.09 billion05/02/2024$7.31$7.50+2.60%$7.58$7.211.07 million shs$1.11 billion05/01/2024$6.16$7.31+18.67%$7.40$6.332.34 million shs$1.08 billion04/30/2024$6.26$6.16-1.60%$6.28$6.121.01 million shs$909.09 million04/29/2024$6.27$6.26-0.16%$6.39$6.241.00 million shs$923.85 million04/26/2024$6.25$6.27+0.40%$6.32$6.18604,808 shs$925.33 million Get the Latest News and Ratings for MDXG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$6.43$6.25-2.88%$6.30$5.651.59 million shs$917.77 million04/24/2024$6.51$6.43-1.23%$6.49$6.37648,215 shs$944.95 million04/23/2024$6.36$6.51+2.36%$6.58$6.30747,281 shs$956.71 million04/22/2024$6.29$6.36+1.11%$6.40$6.25622,981 shs$934.65 million04/19/2024$6.16$6.29+2.11%$6.30$6.10691,192 shs$924.38 million04/18/2024$6.33$6.16-2.69%$6.39$6.16542,394 shs$905.27 million04/17/2024$6.23$6.33+1.61%$6.41$6.20875,010 shs$930.24 million04/16/2024$6.35$6.23-1.89%$6.35$6.19487,711 shs$915.56 million04/15/2024$6.44$6.35-1.40%$6.47$6.34503,722 shs$933.20 million04/12/2024$6.61$6.44-2.57%$6.62$6.39514,312 shs$946.42 million04/11/2024$6.55$6.61+0.92%$6.64$6.47888,776 shs$971.41 million04/10/2024$7.02$6.55-6.70%$6.95$6.451.13 million shs$962.59 million04/09/2024$6.90$7.02+1.74%$7.02$6.85496,757 shs$1.03 billion04/08/2024$7.00$6.90-1.43%$7.04$6.88620,254 shs$1.01 billion04/05/2024$7.02$7.00-0.28%$7.09$6.92499,664 shs$1.03 billion04/04/2024$7.01$7.02+0.14%$7.17$7.00834,920 shs$1.03 billion04/03/2024$6.88$7.01+1.89%$7.12$6.80884,381 shs$1.03 billion04/02/2024$7.45$6.88-7.65%$7.41$6.841.37 million shs$1.01 billion04/01/2024$7.70$7.45-3.25%$7.73$7.301.10 million shs$1.09 billion03/29/2024$7.70$7.70$7.71$7.60943,504 shs$1.13 billion03/28/2024$7.61$7.70+1.18%$7.71$7.60943,504 shs$1.13 billion03/27/2024$7.62$7.61-0.13%$7.82$7.241.82 million shs$1.12 billion03/26/2024$7.83$7.62-2.68%$7.92$7.61739,261 shs$1.12 billion03/25/2024$8.04$7.83-2.61%$8.12$7.78746,701 shs$1.15 billion03/22/2024$8.16$8.04-1.47%$8.17$8.03576,860 shs$1.18 billion03/21/2024$8.20$8.16-0.49%$8.43$8.15799,196 shs$1.20 billion03/20/2024$8.05$8.20+1.86%$8.22$8.00650,718 shs$1.21 billion03/19/2024$7.88$8.05+2.16%$8.10$7.85941,375 shs$1.18 billion03/18/2024$7.88$7.88$7.97$7.75868,916 shs$1.16 billion03/15/2024$7.80$7.88+1.03%$7.96$7.721.84 million shs$1.16 billion03/14/2024$7.95$7.80-1.89%$7.91$7.71994,579 shs$1.15 billion03/13/2024$7.99$7.95-0.50%$8.10$7.901.20 million shs$1.17 billion03/12/2024$8.00$7.99-0.12%$8.10$7.97903,673 shs$1.17 billion03/11/2024$8.16$8.00-1.96%$8.16$7.961.09 million shs$1.18 billionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/08/2024$8.15$8.16+0.12%$8.36$8.10570,215 shs$1.20 billion03/07/2024$8.07$8.15+0.99%$8.24$8.06558,218 shs$948.50 million03/06/2024$8.00$8.07+0.88%$8.15$7.91661,587 shs$939.19 million03/05/2024$8.26$8.00-3.15%$8.27$8.00649,726 shs$931.04 million03/04/2024$8.63$8.26-4.29%$8.80$8.19823,259 shs$961.27 million03/01/2024$8.16$8.63+5.76%$8.73$8.291.67 million shs$1.00 billion02/29/2024$8.20$8.16-0.49%$9.04$8.102.09 million shs$949.66 million02/28/2024$8.40$8.20-2.38%$8.34$8.08774,864 shs$954.32 million02/27/2024$8.26$8.40+1.69%$8.46$8.09790,968 shs$977.59 million02/26/2024$8.20$8.26+0.73%$8.33$8.06598,765 shs$961.30 million02/23/2024$8.18$8.20+0.24%$8.26$8.08523,902 shs$954.32 million02/22/2024$8.06$8.18+1.49%$8.21$8.00630,618 shs$951.99 million02/21/2024$8.04$8.06+0.25%$8.10$7.95498,101 shs$938.02 million02/20/2024$8.06$8.04-0.25%$8.08$7.94610,968 shs$935.70 million02/19/2024$8.06$8.06$8.20$8.01532,200 shs$938.02 million02/16/2024$8.24$8.06-2.18%$8.20$8.01532,219 shs$938.02 million02/15/2024$8.07$8.24+2.11%$8.24$7.98828,074 shs$958.95 million02/14/2024$7.96$8.07+1.38%$8.17$7.96887,290 shs$939.16 million02/13/2024$8.30$7.96-4.10%$8.24$7.92817,718 shs$926.39 million02/12/2024$7.96$8.30+4.27%$8.31$7.93728,548 shs$965.95 million02/09/2024$7.78$7.96+2.31%$8.02$7.79575,273 shs$926.39 million02/08/2024$7.75$7.78+0.39%$7.93$7.71609,858 shs$905.44 million02/07/2024$7.78$7.75-0.39%$7.83$7.72541,444 shs$901.95 million02/06/2024$7.68$7.78+1.30%$7.79$7.61781,430 shs$905.44 million02/05/2024$7.77$7.68-1.16%$7.77$7.64748,564 shs$893.80 million Related Companies: Artivion Stock Price Chart Paragon 28 Stock Price Chart AtriCure Stock Price Chart OrthoPediatrics Stock Price Chart Atrion Stock Price Chart Silk Road Medical Stock Price Chart Treace Medical Concepts Stock Price Chart SI-BONE Stock Price Chart Embecta Stock Price Chart NovoCure Stock Price Chart Receive MDXG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDXG) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.